Document:

synh-ex1016_4335.htm

Exhibit 10.16.2

 

EXECUTION VERSION

FIRST AMENDMENT TO THE

PURCHASE AND SALE AGREEMENT

THIS FIRST AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of January 2, 2019, is entered into among the VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO, as originators (each, an “Originator”; and collectively, the “Originators”), and SYNEOS HEALTH, LLC (f/k/a INC RESEARCH, LLC), as servicer (in such capacity, the “Servicer”) and SYNEOS HEALTH RECEIVABLES LLC (the “Buyer”).

Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Purchase and Sale Agreement described below.

BACKGROUND

A.The parties hereto have entered into a Purchase and Sale Agreement, dated as of June 29, 2018 (as amended, restated, supplemented or otherwise modified through the date hereof, the “Purchase and Sale Agreement”).

B.Concurrently herewith, the Buyer, as borrower, the Servicer and PNC Bank, National Association, as administrative agent and as a lender (the “Administrative Agent”) are entering into that certain Fourth Amendment to Receivables Financing Agreement, dated as of the date hereof (the “RFA Amendment”).

C.Concurrently herewith, the Borrower, the Servicer, the Administrative Agent and Bank of America, N.A. are entering into that certain First Amendment to the Deposit Account Control Agreement, dated as of the date hereof.

D.Concurrently herewith, the Borrower, the Servicer, the Administrative Agent and Wells Fargo Bank, National Association are entering into that certain First Amendment to the Deposit Account Control Agreement, dated as of the date hereof.

E.Effective as of the date hereof, INC Research, LLC, a Delaware limited liability company, is changing its name from “INC Research, LLC” to “Syneos Health, LLC”.

F.The parties hereto desire to amend the Purchase and Sale Agreement as hereinafter set forth.

NOW THEREFORE, with the intention of being legally bound hereby, and in consideration of the mutual undertakings expressed herein, each party to this Amendment hereby agrees as follows:

SECTION 1.Amendments to the Purchase and Sale Agreement.  The Purchase and Sale Agreement is hereby amended as follows:

(a)Schedule I to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule I attached hereto.

730860557 18569090

 

(b)Schedule II to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule II attached hereto.

(c)Schedule III to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule III attached hereto.

(d)Schedule IV to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule IV attached hereto.

SECTION 2.Representations and Warranties of the Originators.  Each Originator hereby represents and warrants as of the date hereof as follows:

(a)Representations and Warranties.  The representations and warranties made by it in the Purchase and Sale Agreement and each of the other Transaction Documents to which it is a party are true and correct as of the date hereof.

(b)Enforceability.  The execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are within its organizational powers and have been duly authorized by all necessary action on its part, and this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are (assuming due authorization and execution by the other parties thereto) its valid and legally binding obligations, enforceable in accordance with their terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.

(c)No Event of Default. No Purchase and Sale Termination Event, Unmatured Purchase and Sale Termination Event, Event of Default or Unmatured Event of Default has occurred and is continuing, or would occur as a result of this Amendment or the transactions contemplated hereby.

SECTION 3.Effect of Amendment; Ratification.  All provisions of the Purchase and Sale Agreement and the other Transaction Documents, as expressly amended and modified by this Amendment, shall remain in full force and effect. After this Amendment becomes effective, all references in the Purchase and Sale Agreement (or in any other Transaction Document) to “this Agreement”, “hereof”, “herein” or words of similar effect referring to the Purchase and Sale Agreement shall be deemed to be references to the Purchase and Sale Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Purchase and Sale Agreement other than as set forth herein. The Purchase and Sale Agreement, as amended by this Amendment, is hereby ratified and confirmed in all respects.

SECTION 4.Effectiveness.  This Amendment shall become effective concurrently with the effectiveness of the RFA Amendment.

 

	
730860557 18569090
	
2
	
 

 

 

SECTION 5.Authorization to File Financing Statement Amendments.  Upon the effectiveness of this Amendment, each of the parties hereto hereby authorize the Administrative Agent to file (at the expense of the Buyer) UCC-3 amendments in substantially the form of Exhibit A hereto amending the UCC-1 financing statements identified on Exhibit B hereto.

SECTION 6.Severability.  Any provisions of this Amendment which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

SECTION 7.Transaction Document.  This Amendment shall be a Transaction Document for purposes of the Receivables Financing Agreement.

SECTION 8.Counterparts.  This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.  Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart.

SECTION 9.GOVERNING LAW AND JURISDICTION. 

(a)THIS AMENDMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).

(b)EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO (I) WITH RESPECT TO THE BUYER, THE ORIGINATORS AND THE SERVICER, THE EXCLUSIVE JURISDICTION, AND (II) WITH RESPECT TO EACH OF THE OTHER PARTIES HERETO, THE NON-EXCLUSIVE JURISDICTION, IN EACH CASE, OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING (I) IF BROUGHT BY THE BUYER, THE SERVICER, ANY ORIGINATOR OR ANY AFFILIATE THEREOF, SHALL BE HEARD AND DETERMINED, AND (II) IF BROUGHT BY ANY OTHER PARTY TO THIS AMENDMENT, MAY BE HEARD AND DETERMINED, IN EACH CASE, IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT.  NOTHING IN THIS SECTION 9 SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE AGENT OR ANY OTHER CREDIT PARTY TO BRING ANY ACTION OR PROCEEDING AGAINST THE BUYER OR THE SERVICER OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS.  EACH OF THE BUYER, EACH ORIGINATOR AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR 

 

	
730860557 18569090
	
3
	
 

 

 

PROCEEDING.  THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.

SECTION 10.Section Headings.  The various headings of this Amendment are included for convenience only and shall not affect the meaning or interpretation of this Amendment, the Purchase and Sale Agreement or any provision hereof or thereof.

 [Signature pages follow]

 

	
730860557 18569090
	
4
	
 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.

 

 

	
SYNEOS HEALTH, LLC,

	
as the Servicer and as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Jason Meggs

	
Name:
	
Jason Meggs

	
Title:
	
Chief Financial Officer

	
 
	
 

	
 
	
 

	
INVENTIV HEALTH CLINICAL, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Thomas E. Zajkowski

	
Name:
	
Thomas E. Zajkowski

	
Title:
	
Treasurer

 

 

	
730860557 18569090
	
S-1
	
First Amendment to the Purchase and Sale Agreement

 

 

 

	
SYNEOS HEALTH RECEIVABLES LLC,

	
as the Buyer

	
 
	
 

	
 
	
 

	
By:
	
/s/ Thomas E. Zajkowski

	
Name:
	
Thomas E. Zajkowski

	
Title:
	
President

 

	
730860557 18569090
	
S-2
	
First Amendment to the Purchase and Sale Agreement

 

 

Consented to:

 

PNC BANK, NATIONAL ASSOCIATION,

as Administrative Agent and as a Lender

	
 
	
 

	
By:
	
/s/ Christopher Blaney

	
Name:
	
Christopher Blaney

	
Title:
	
Senior Vice President

 

 

 

	
730860557 18569090
	
S-3
	
First Amendment to the Purchase and Sale Agreement

 

 

 

Schedule I

LIST AND LOCATION OF EACH ORIGINATOR

 

 

		
	
Originator
	
Location

	
Syneos Health, LLC
	
Delaware

	
inVentiv Health Clinical, LLC
	
Delaware

 

 

 

 

	
730860557 18569090
	
Schedule I-1
	
Purchase and Sale Agreement (QINC)

 

 

 

Schedule II

LOCATION OF BOOKS AND RECORDS OF ORIGINATORS

 

 

		
	
Originator
	
Location of Books and Records

	
Syneos Health, LLC
	
1030 Sync Street, Morrisville, NC 27560

	
inVentiv Health Clinical, LLC
	
1030 Sync Street, Morrisville, NC 27560

 

 

	
730860557 18569090
	
Schedule II-1
	
Purchase and Sale Agreement (QINC)

 

 

 

Schedule III

TRADE NAMES

 

Syneos Health, LLC

 

Syneos Health, LLC was formerly known as INC Research, LLC

 

Syneos Health has been used as a trade name since January 4, 2018.

 

Syneos Health, LLC has qualified to do business in the State of California under the name “Integrated Neurosciences Consortium, LLC”.

 

 

inVentiv Health Clinical, LLC

 

 

Syneos Health has been used as a trade name since January 4, 2018.

 

	
730860557 18569090
	
Schedule III -1
	
Purchase and Sale Agreement

 

 

 

Schedule IV

NOTICE ADDRESSES

If to Syneos Health, LLC:

 

Syneos Health, LLC 

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Wyrick Robbins Yates & Ponton LLP

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

Attention:  Carolyn W. Minshall, Esq.

 

 

If to inVentiv Health Clinical, LLC:

 

inVentiv Health Clinical, LLC 

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to:

 

Wyrick Robbins Yates & Ponton LLP

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

Attention:  Carolyn W. Minshall, Esq.

 

 

 

 

	
730860557 18569090
	
Schedule IV-1
	
 

 

 

 

Exhibit A

UCC-3s TO BE FILED

 

	
730860557 18569090
	
Exhibit A-1
	
 
	
 
	
 

 

 

 

Exhibit B

UCC-1 TO BE AMENDED

 

 

				
	
Debtor
	
Filing Office
	
Identification Number
	
Filing Date

	
INC Research, LLC
	
Delaware Secretary of State
	
20184470841
	
6/29/2018

	
inVentiv Health Clinical, LLC
	
Delaware Secretary of State
	
20184470494
	
6/29/2018

	
Syneos Health Receivables LLC
	
Delaware Secretary of State
	
20184471195
	
6/29/2018

 

 

	
730860557 18569090
	
Exhibit B-1synh-ex1016_4334.htm

Exhibit 10.16.5

 

EXECUTION VERSION

FIFTH AMENDMENT TO THE
PURCHASE AND SALE AGREEMENT

THIS FIFTH AMENDMENT TO THE PURCHASE AND SALE AGREEMENT (this “Amendment”), dated as of January 28, 2021, is entered into among each of the entities listed on the signature pages hereto as an Originator (each an “Originator”, and collectively, the “Originators”), and SYNEOS HEALTH, LLC (f/k/a INC RESEARCH, LLC) (“Syneos Health”), as servicer (in such capacity, the “Servicer”) and SYNEOS HEALTH RECEIVABLES LLC (the “Buyer”).

Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Purchase and Sale Agreement described below.

BACKGROUND

A.The parties hereto have entered into a Purchase and Sale Agreement, dated as of June 29, 2018 (as amended, restated, supplemented or otherwise modified through the date hereof, the “Purchase and Sale Agreement”).

B.Concurrently herewith, the Buyer, as borrower, the Servicer and PNC Bank, National Association, as administrative agent and as a lender (the “Administrative Agent”) are entering into that certain Tenth Amendment to Receivables Financing Agreement, dated as of the date hereof (the “RFA Amendment”).

C.Effective as of the January 11, 2021, (such date, the “inVentiv Name Change Date”), inVentiv Commercial Services, LLC, a New Jersey limited liability company, changed its name from “inVentiv Commercial Services, LLC” to “Syneos Health Commercial Services, LLC”.

D.The parties hereto desire to amend the Purchase and Sale Agreement as hereinafter set forth.  

NOW THEREFORE, with the intention of being legally bound hereby, and in consideration of the mutual undertakings expressed herein, each party to this Amendment hereby agrees as follows:

SECTION 1.Amendments to the Purchase and Sale Agreement.  As of the inVentiv Name Change date, the Purchase and Sale Agreement is hereby amended as follows:

(a)Schedule I to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule I attached hereto.

(b)Schedule II to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule II attached hereto.

(c)Schedule III to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule III attached hereto.

739347366 18569090

 

(d)Schedule IV to the Purchase and Sale Agreement is hereby replaced in its entirety with Schedule IV attached hereto.

SECTION 2.Representations and Warranties of the Originators.  Each Originator hereby represents and warrants as of the date hereof as follows:

(a)Representations and Warranties.  The representations and warranties made by it in the Purchase and Sale Agreement and each of the other Transaction Documents to which it is a party are true and correct as of the date hereof.

(b)Enforceability.  The execution and delivery by it of this Amendment, and the performance of its obligations under this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are within its organizational powers and have been duly authorized by all necessary action on its part, and this Amendment, the Purchase and Sale Agreement (as amended hereby) and the other Transaction Documents to which it is a party are (assuming due authorization and execution by the other parties thereto) its valid and legally binding obligations, enforceable in accordance with their terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and (ii) as such enforceability may be limited by general principles of equity, regardless of whether such enforceability is considered in a proceeding in equity or at law.

(c)No Event of Default. No Purchase and Sale Termination Event, Unmatured Purchase and Sale Termination Event, Event of Default or Unmatured Event of Default has occurred and is continuing, or would occur as a result of this Amendment or the transactions contemplated hereby.

SECTION 3.Effect of Amendment; Ratification.  All provisions of the Purchase and Sale Agreement and the other Transaction Documents, as expressly amended and modified by this Amendment, shall remain in full force and effect. After this Amendment becomes effective, all references in the Purchase and Sale Agreement (or in any other Transaction Document) to “the Purchase and Sale Agreement”, “this Agreement”, “hereof”, “herein” or words of similar effect referring to the Purchase and Sale Agreement shall be deemed to be references to the Purchase and Sale Agreement as amended by this Amendment. This Amendment shall not be deemed, either expressly or impliedly, to waive, amend or supplement any provision of the Purchase and Sale Agreement other than as set forth herein. The Purchase and Sale Agreement, as amended by this Amendment, is hereby ratified and confirmed in all respects.

SECTION 4.Effectiveness.  This Amendment shall become effective concurrently with the effectiveness of the RFA Amendment.

SECTION 5.Authorization to File Financing Statement Amendments.  Upon the effectiveness of this Amendment, each of the parties hereto hereby authorize the Administrative Agent to file (at the expense of the Buyer) UCC-3 amendments in substantially the form of Exhibit A hereto amending the UCC-1 financing statements identified on Exhibit B hereto.

 

	
739347366 18569090
	
2
	
 

 

 

SECTION 6.Severability.  Any provisions of this Amendment which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

SECTION 7.Transaction Document.  This Amendment shall be a Transaction Document for purposes of the Receivables Financing Agreement.

SECTION 8.Counterparts.  This Amendment may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.  Delivery of an executed counterpart hereof by facsimile or other electronic means shall be equally effective as delivery of an originally executed counterpart. The words “execution,” “execute”, “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.

SECTION 9.GOVERNING LAW AND JURISDICTION. 

(a)THIS AMENDMENT, INCLUDING THE RIGHTS AND DUTIES OF THE PARTIES HERETO, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BUT WITHOUT REGARD TO ANY OTHER CONFLICTS OF LAW PROVISIONS THEREOF).

(b)EACH PARTY HERETO HEREBY IRREVOCABLY SUBMITS TO (I) WITH RESPECT TO THE BUYER, THE ORIGINATORS AND THE SERVICER, THE EXCLUSIVE JURISDICTION, AND (II) WITH RESPECT TO EACH OF THE OTHER PARTIES HERETO, THE NON-EXCLUSIVE JURISDICTION, IN EACH CASE, OF ANY NEW YORK STATE OR FEDERAL COURT SITTING IN NEW YORK CITY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, AND EACH PARTY HERETO HEREBY IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION OR PROCEEDING (I) IF BROUGHT BY THE BUYER, THE SERVICER, ANY ORIGINATOR OR ANY AFFILIATE THEREOF, SHALL BE HEARD AND DETERMINED, AND (II) IF BROUGHT BY ANY OTHER PARTY TO THIS AMENDMENT, MAY BE HEARD AND DETERMINED, IN EACH CASE, IN SUCH NEW YORK STATE COURT OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT.  NOTHING IN THIS SECTION 9 SHALL AFFECT THE RIGHT OF THE ADMINISTRATIVE 

 

	
739347366 18569090
	
3
	
 

 

 

AGENT OR ANY OTHER CREDIT PARTY TO BRING ANY ACTION OR PROCEEDING AGAINST THE BUYER OR THE SERVICER OR ANY OF THEIR RESPECTIVE PROPERTY IN THE COURTS OF OTHER JURISDICTIONS.  EACH OF THE BUYER, EACH ORIGINATOR AND THE SERVICER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING.  THE PARTIES HERETO AGREE THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.

SECTION 10.Section Headings.  The various headings of this Amendment are included for convenience only and shall not affect the meaning or interpretation of this Amendment, the Purchase and Sale Agreement or any provision hereof or thereof.

 [Signature pages follow]

 

	
739347366 18569090
	
4
	
 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.

 

 

				
	
 
	
 

	
SYNEOS HEALTH, LLC,

	
as the Servicer and as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Jason Meggs

	
Name:
	
Jason Meggs

	
Title:
	
Chief Financial Officer

 

 

				
	
 
	
 

	
SYNEOS HEALTH COMMERCIAL SERVICES, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Jason Meggs

	
Name:
	
Jason Meggs

	
Title:
	
Manager

 

 

 

				
	
 
	
 

	
ADDISON WHITNEY LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
 

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

				
	
 
	
 

	
BIOSECTOR 2 LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
 

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

 

	
739347366 18569090
	
S-1
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment by their duly authorized officers as of the date first above written.

 

			
	
SYNEOS HEALTH, LLC,

	
as the Servicer and as an Originator

	
 
	
 

	
By:
	
 

	
Name:
	
Jason Meggs

	
Title:
	
Manager

 

 

			
	
SYNEOS HEALTH COMMERCIAL

SERVICES, LLC,

	
as an Originator

	
 
	
 

	
By:
	
 

	
Name:
	
Jason Meggs

	
Title:
	
Manager

 

				
	
 
	
 

	
ADDISON WHITNEY LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

				
	
 
	
 

	
BIOSECTOR 2 LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

	
739347366 18569090
	
S-1
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

				
	
 
	
 

	
CADENT MEDICAL COMMUNICATIONS, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

				
	
 
	
 

	
CHAMBERLAIN COMMUNICATIONS GROUP LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

				
	
 
	
 

	
CHANDLER CHICCO AGENCY, L.L.C.,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President

 

 

				
	
 
	
 

	
GERBIG, SNELL/WEISHEIMER ADVERTISING, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

 

 

 

	
739347366 18569090
	
S-2
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

 

				
	
 
	
 

	
SYNEOS HEALTH MEDICAL COMMUNICATIONS, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

				
	
 
	
 

	
NAVICOR GROUP, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

				
	
 
	
 

	
PALIO + IGNITE, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

			
	
 
	
 

	
THE SELVA GROUP, LLC

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

	
739347366 18569090
	
S-3
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

			
	
 
	
 

	
SYNEOS HEALTH COMMUNICATIONS, INC.,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Secretary

 

 

			
	
 
	
 

	
TAYLOR STRATEGY PARTNERS, LLC,

	
as an Originator

	
 

	
 
	
 

	
By:
	
/s/ Sara Epstein

	
Name:
	
Sara Epstein

	
Title:
	
Vice President and Assistant Secretary

 

 

 

 

	
739347366 18569090
	
S-4
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

 

			
	
 
	
 

	
SYNEOS HEALTH RECEIVABLES LLC,

	
as the Buyer

	
 

	
 
	
 

	
By:
	
/s/ Robert Parks

	
Name:
	
Robert Parks

	
Title:
	
President

 

 

 

 

	
739347366 18569090
	
S-5
	
Fifth Amendment to the Purchase

and Sale Agreement

 

 

 

Schedule I

LIST AND LOCATION OF EACH ORIGINATOR

 

		
	
Originator
	
Location

	
Syneos Health, LLC
	
Delaware

	
Syneos Health Commercial  Services, LLC
	
New Jersey

	
Addison Whitney LLC
	
North Carolina

	
BioSector 2 LLC
	
New York

	
Cadent Medical Communications, LLC
	
Ohio

	
Chamberlain Communications Group LLC
	
Delaware

	
Chandler Chicco Agency, L.L.C.
	
New York

	
Gerbig, Snell/Weisheimer Advertising, LLC
	
Ohio

	
Syneos Health Medical Communications, LLC
	
Ohio

	
Navicor Group, LLC
	
Ohio

	
Palio + Ignite, LLC
	
Ohio

	
Syneos Health Communications, Inc.
	
Ohio

	
The Selva Group, LLC
	
Ohio

	
Taylor Strategy Partners, LLC
	
Ohio

 

 

 

	
739347366 18569090
	
Schedule I-1
	
Purchase and Sale Agreement (QINC)

 

 

 

Schedule II

LOCATION OF BOOKS AND RECORDS OF ORIGINATORS

		
	
Originator
	
Location of Books and Records

	
Syneos Health, LLC
	
1030 Sync Street, Morrisville, NC 27560

	
Syneos Health Commercial  Services, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Addison Whitney LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
BioSector 2 LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
CADENT MEDICAL COMMUNICATIONS, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Chamberlain Communications Group LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
CHANDLER CHICCO AGENCY, L.L.C.
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
GERBIG, SNELL/WEISHEIMER ADVERTISING, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Syneos Health Medical Communications, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
NAVICOR GROUP, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Palio + Ignite, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Syneos Health Communications, Inc.
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
THE SELVA GROUP, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

	
Taylor Strategy Partners, LLC
	
470 Atlantic Avenue, 11th Floor, Boston, MA 02210

 

 

	
739347366 18569090
	
Schedule II-1
	
Purchase and Sale Agreement (QINC)

 

 

 

Schedule III

TRADE NAMES

Syneos Health, LLC

Syneos Health, LLC was formerly known as INC Research, LLC, INC Research, Inc., and Integrated Neuroscience Consortium, Inc.

Syneos Health has been used as a trade name since January 4, 2018.

Syneos Health, LLC has qualified to do business in the State of California.

Syneos Health Commercial  Services, LLC

Syneos Health Commercial Services, LLC was formerly known as inVentiv Commercial Services, LLC; Ventiv Commercial Services, LLC; Ventiv Pharma Services, LLC; and Ventiv Health US. Sales LLC.

Syneos Health has been used as a trade name since January 4, 2018.

inVentiv Commercial Services, LLC has qualified to do business in the State of New Jersey and the State of Texas under the name “inVentiv Commercial, LLC”.

Addison Whitney LLC

Addison Whitney LLC was formerly known as AW Acquisition LLC.

 

BioSector 2 LLC

BioSector 2 LLC was formerly known as Sector 2 LLC.

 

Cadent Medical Communications, LLC

Cadent Medical Communications, LLC was formerly known as S.G. Madison & Associates, LLC.

 

Cadent Medical Communications, LLC has qualified to do business in the State of Ohio under the name “Cadent Medical Communications”.

 

Chamberlain Communications Group LLC

Chamberlain Communications Group LLC was formerly known as Chamberlin Communications LLC.

 

Chandler Chicco Agency, L.L.C.

 

	
739347366 18569090
	
Schedule III -1
	
Purchase and Sale Agreement

 

 

N/A

Gerbig, Snell/Weisheimer Advertising, LLC

N/A

 

Syneos Health Medical Communications, LLC

Syneos Health Medical Communications, LLC was formerly known as inVentiv Medical Communications, LLC and inVentiv Medical Education Group, LLC.

Navicor Group, LLC

N/A

 

Palio + Ignite, LLC

Palio + Ignite, LLC was formerly known as Palio Communications, LLC.

 

The Selva Group, LLC

N/A

 

Syneos Health Communications, Inc.

Syneos Health Communications, Inc. was formerly known as inVentiv Health Communications, Inc, inVentiv Communications, Inc., inChord Communications, Inc., Gerbig, Snell/Weisheimer & Associates, Inc., and Gerbig, Snell, Weisheimer & Associates, Inc.

 

Syneos Health Communications, Inc. has qualified to do business in the state of New York under the name “inVentiv Communications, Inc.”

 

Taylor Strategy Partners, LLC

Taylor Strategy Partners, LLC was formerly known as Taylor Search Partners, LLC

 

 

 

	
739347366 18569090
	
Schedule III -2
	
Purchase and Sale Agreement

 

 

 

Schedule IV

NOTICE ADDRESSES

If to Syneos Health, LLC:

 

Syneos Health, LLC 

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Syneos Health Commercial Services, LLC:

 

Syneos Health Commercial Services, LLC 

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to:

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Addison Whitney LLC:

 

Addison Whitney LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

 

	
739347366 18569090
	
Schedule IV-1
	
Purchase and Sale Agreement

 

 

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to BioSector 2 LLC:

 

BioSector 2 LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Cadent Medical Communications, LLC :

 

Cadent Medical Communications, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Chamberlain Communications Group LLC :

 

Chamberlain Communications Group LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

 

	
739347366 18569090
	
Schedule IV-2
	
Purchase and Sale Agreement

 

 

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Chandler Chicco Agency, L.L.C.:

 

Chandler Chicco Agency, L.L.C.

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Gerbig, Snell/Weisheimer Advertising, LLC:

 

Gerbig, Snell/Weisheimer Advertising, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Syneos Health Medical Communications LLC:

 

Syneos Health Medical Communications LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

 

	
739347366 18569090
	
Schedule IV-3
	
Purchase and Sale Agreement

 

 

Attention:  Graeme Smyth, Esq.

 

If to Navicor Group, LLC:

 

Navicor Group, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Palio + Ignite, LLC:

 

Palio + Ignite, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to The Selva Group, LLC:

 

The Selva Group, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

	
739347366 18569090
	
Schedule IV-4
	
Purchase and Sale Agreement

 

 

 

If to Syneos Health Communications, Inc.:

 

Syneos Health Communications, Inc.

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

If to Taylor Strategy Partners, LLC:

 

Taylor Strategy Partners, LLC

c/o Syneos Health, Inc.

1030 Sync Street

Morrisville, NC 27560

Attention:  General Counsel

 

with a copy to: 

 

Latham & Watkins LLP

885 3rd Avenue

New York, NY 10022-4834

Attention:  Graeme Smyth, Esq.

 

 

 

	
739347366 18569090
	
Schedule IV-5
	
Purchase and Sale Agreement

 

 

 

Exhibit A

UCC-3s TO BE FILED

 

 

 

	
739347366 18569090
	
Exhibit A-1
	
Purchase and Sale Agreement

 

 

 

Exhibit B

UCC-1 TO BE AMENDED

 

				
	
Debtor
	
Filing Office
	
Identification Number
	
Filing Date

	
Syneos Health Commercial Services, LLC (f/k/a inVentiv Commercial Services, LLC)
	
New Jersey Secretary of State
	
26735252
	
07/25/2019

 

 

 

	
739347366 18569090
	
Exhibit B-1
	
Purchase and Sale Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]